Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters.

Source:http://linkedlifedata.com/resource/pubmed/id/21036890

Download in:

View as

General Info

PMID
21036890